Patent: 10,196,695
✉ Email this page to a colleague
Summary for Patent: 10,196,695
Title: | RNA-biomarkers for diagnosis of prostate cancer |
Abstract: | The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays. |
Inventor(s): | Horn; Friedemann (Leipzig, DE), Hackermuller; Jorg (Leipzig, DE), Christ; Sabina (Leipzig, DE), Reiche; Kristin (Leipzig, DE), Wirth; Manfred (Leipzig, DE), Frohner; Michael (Leipzig, DE), Fussel; Susanne (Leipzig, DE) |
Assignee: | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG (Munchen, CN) |
Application Number: | 15/100,943 |
Patent Claims: | see list of patent claims |
Details for Patent 10,196,695
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Dendreon Pharmaceuticals Llc | PROVENGE | sipuleucel-t | Injection | 125197 | 04/29/2010 | ⤷ Try a Trial | 2033-12-02 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |